Research and Markets: Research Report on the $6.8 billion U.S. Market for Cardiac Rhythm Managment, Electrophysiology and Ablation

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hkjrfh/u_s_market_for) has announced the addition of the "U.S. Market for Cardiac Rhythm Managment, Electrophysiology and Ablation" report to their offering.

“U.S. Market for Cardiac Rhythm Managment, Electrophysiology and Ablation”

In 2012, the U.S. market for cardiac rhythm management (CRM), electrophysiology and ablation devices market was valued at nearly $6.8 billion.

The CRM, electrophysiology and ablation device market includes pacemakers, cardiac resynchronization therapy (CRT) devices, implantable cardioverter defibrillators (ICDs), cardiac stimulation leads, external defibrillators, ablation catheters, diagnostic electrophysiology (EP) catheters, intracardiac ultrasound (ICE) catheters, electrophysiology (EP) stimulators, diagnostic ECG and cardiac monitoring devices.

Over the forecast period, the CRM, electrophysiology and ablation device market will be driven by the aging population, rise in cardiac ablation procedures and adoption of advanced CRM devices. However, the aftermath of the economic recession of 2008 and the sluggish U.S. economy that followed have continued to stifle growth in the markets.

Scope: This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S.

Key Topics Covered:

Executive Summary

Research Methodology

Device Market

Pacemaker Market

Implantable Cardioverter Defibrillator Market

Cardiac Resynchronization Theraphy Device Market

Cardiac Lead Market

External Defibrillator Market

Cardiac Ablation Market

Diagnostic Electrophysiology Device Market